Literature DB >> 29103006

A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation.

Quan M Nhu1,2, Emma Z Du3, Amirali Kiyani4, Catherine T Frenette5.   

Abstract

Cutaneous T-cell post-transplant lymphoproliferative disorder (PTLD) is a rare clinical presentation that can potentially turn aggressive in solid-organ transplant recipients if not detected and intervened on early. We encountered a rare case of rapidly worsening primary cutaneous CD30-positive, Epstein-Barr virus-negative anaplastic large cell lymphoma (ALCL) of T-cell origin, manifesting as an isolated nasal tip lesion in a 71-year-old man 4 years after orthotopic liver transplantation. Excisional biopsy with partial rhinectomy showed subepithelial diffuse infiltration of medium-to-large lymphoid cells having round-to-irregular nuclei, partially condensed chromatin and prominent nucleoli. Immunophenotypic studies revealed CD30-positive primary cutaneous ALCL. Positron emission tomography/CT imaging revealed a locally active disease, and radiation therapy was initiated with complete response. A high index of suspicion for PTLD when evaluating skin lesions in a post-transplant patient is paramount for its early recognition, prompt diagnosis and timely intervention while the window for curative therapy remains possible. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); liver disease; oncology; pathology; transplantation

Mesh:

Year:  2017        PMID: 29103006      PMCID: PMC5747785          DOI: 10.1136/bcr-2017-221028

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.

Authors:  Rebecca G Pomerantz; Lauren S Campbell; Drazen M Jukic; Larisa J Geskin
Journal:  Arch Dermatol       Date:  2010-05

3.  Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.

Authors:  Robin D Kim; Takahisa Fujikawa; Shugo Mizuno; Jason J Schwartz; John B Sorensen; Alan W Hemming; Shiro Fujita
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-07       Impact factor: 2.566

4.  Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C.

Authors:  K McLaughlin; S Wajstaub; P Marotta; P Adams; D R Grant; W J Wall; A M Jevnikar; K S Rizkalla
Journal:  Liver Transpl       Date:  2000-09       Impact factor: 5.799

Review 5.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

6.  Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

Authors:  C Hézode; C Duvoux; G Germanidis; F Roudot-Thoraval; A L Vincens; P Gaulard; D Cherqui; J M Pawlotsky; D Dhumeaux
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

Review 7.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

8.  Post-transplant EBV-negative anaplastic large-cell lymphoma with dual rearrangement: a propos of two cases and review of the literature.

Authors:  Cynthia M Magro; David J Weinerman; Pierre Luigi Porcu; Carl D Morrison
Journal:  J Cutan Pathol       Date:  2007-12       Impact factor: 1.587

9.  Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.

Authors:  D Seçkin; S Barete; S Euvrard; C Francès; J Kanitakis; A Geusau; V Del Marmol; C A Harwood; C M Proby; I Ali; A T Güleç; E Durukan; C Lebbé; M Alaibac; E Laffitte; S Cooper; J N Bouwes Bavinck; G M Murphy; C Ferrándiz; C Mørk; P Cetkovská; W Kempf; G F L Hofbauer
Journal:  Am J Transplant       Date:  2013-05-29       Impact factor: 8.086

Review 10.  Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

Authors:  Pavan Kedar Mukthinuthalapati; Raghavender Gotur; Marwan Ghabril
Journal:  World J Hepatol       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.